Prospective association of vascular endothelial growth factor-A (VEGF-A) with coronary heart disease mortality in Southeastern New England

Charles B. Eaton, Robert Gramling, Donna Parker, Mary B. Roberts, Bing Lu, Paul M. Ridker

Research output: Contribution to journalArticle

Abstract

Background: Autopsy data suggest that plaque neovascularization may be associated with coronary heart disease (CHD) death. Since vascular endothelial growth factor-A (VEGF-A) is upregulated in angiogenesis and therefore neovascularization, we hypothesized that individuals with elevated levels of VEGF-A at baseline would be a greater risk of dying of CHD compared to those with lower levels over time. Methods: We measured VEGF-A levels in 46 CHD death cases and a 14% random sample of 2321 community participants who were free of self-reported CHD at baseline. Traditional CHD risk factors such as age, gender, family history of CHD, cigarette smoking, hypertension, total cholesterol/HDL ratio, diabetes mellitus, were also evaluated at baseline. Mortality follow-up was determined through linkage of baseline data with the National Death Index. Results: During a median of 13 years of follow-up, 46 subjects died of coronary heart disease. Mean VEGF-A levels were significantly higher in the CHD death cases than among the random population sample (400 pg/ml vs. 303 pg/ml, p = 0.0004). In proportional hazards models adjusting for traditional risk factors, the hazard ratios (95%CI) for CHD death associated with increasing tertiles of VEGF-A were 1.0 (referent), 2.12 (0.74, 6.10), and 3.85 (1.37, 10.78), respectively (Ptest for trend = 0.008). Conclusion: In this population-based prospective, case-cohort study, baseline levels of VEGF-A showed a significant independent association with the risk of CHD death.

Original languageEnglish (US)
Pages (from-to)221-227
Number of pages7
JournalAtherosclerosis
Volume200
Issue number1
DOIs
StatePublished - Sep 2008
Externally publishedYes

Fingerprint

New England
Vascular Endothelial Growth Factor A
Coronary Disease
Mortality
Information Storage and Retrieval
Proportional Hazards Models
HDL Cholesterol
Population
Autopsy
Diabetes Mellitus
Cohort Studies
Smoking
Hypertension

Keywords

  • Coronary heart disease
  • hs-CRP
  • VEGF-A

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Prospective association of vascular endothelial growth factor-A (VEGF-A) with coronary heart disease mortality in Southeastern New England. / Eaton, Charles B.; Gramling, Robert; Parker, Donna; Roberts, Mary B.; Lu, Bing; Ridker, Paul M.

In: Atherosclerosis, Vol. 200, No. 1, 09.2008, p. 221-227.

Research output: Contribution to journalArticle

Eaton, Charles B. ; Gramling, Robert ; Parker, Donna ; Roberts, Mary B. ; Lu, Bing ; Ridker, Paul M. / Prospective association of vascular endothelial growth factor-A (VEGF-A) with coronary heart disease mortality in Southeastern New England. In: Atherosclerosis. 2008 ; Vol. 200, No. 1. pp. 221-227.
@article{09b3ab84276a4e8a9b5cd7f165e81274,
title = "Prospective association of vascular endothelial growth factor-A (VEGF-A) with coronary heart disease mortality in Southeastern New England",
abstract = "Background: Autopsy data suggest that plaque neovascularization may be associated with coronary heart disease (CHD) death. Since vascular endothelial growth factor-A (VEGF-A) is upregulated in angiogenesis and therefore neovascularization, we hypothesized that individuals with elevated levels of VEGF-A at baseline would be a greater risk of dying of CHD compared to those with lower levels over time. Methods: We measured VEGF-A levels in 46 CHD death cases and a 14{\%} random sample of 2321 community participants who were free of self-reported CHD at baseline. Traditional CHD risk factors such as age, gender, family history of CHD, cigarette smoking, hypertension, total cholesterol/HDL ratio, diabetes mellitus, were also evaluated at baseline. Mortality follow-up was determined through linkage of baseline data with the National Death Index. Results: During a median of 13 years of follow-up, 46 subjects died of coronary heart disease. Mean VEGF-A levels were significantly higher in the CHD death cases than among the random population sample (400 pg/ml vs. 303 pg/ml, p = 0.0004). In proportional hazards models adjusting for traditional risk factors, the hazard ratios (95{\%}CI) for CHD death associated with increasing tertiles of VEGF-A were 1.0 (referent), 2.12 (0.74, 6.10), and 3.85 (1.37, 10.78), respectively (Ptest for trend = 0.008). Conclusion: In this population-based prospective, case-cohort study, baseline levels of VEGF-A showed a significant independent association with the risk of CHD death.",
keywords = "Coronary heart disease, hs-CRP, VEGF-A",
author = "Eaton, {Charles B.} and Robert Gramling and Donna Parker and Roberts, {Mary B.} and Bing Lu and Ridker, {Paul M.}",
year = "2008",
month = "9",
doi = "10.1016/j.atherosclerosis.2007.12.027",
language = "English (US)",
volume = "200",
pages = "221--227",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Prospective association of vascular endothelial growth factor-A (VEGF-A) with coronary heart disease mortality in Southeastern New England

AU - Eaton, Charles B.

AU - Gramling, Robert

AU - Parker, Donna

AU - Roberts, Mary B.

AU - Lu, Bing

AU - Ridker, Paul M.

PY - 2008/9

Y1 - 2008/9

N2 - Background: Autopsy data suggest that plaque neovascularization may be associated with coronary heart disease (CHD) death. Since vascular endothelial growth factor-A (VEGF-A) is upregulated in angiogenesis and therefore neovascularization, we hypothesized that individuals with elevated levels of VEGF-A at baseline would be a greater risk of dying of CHD compared to those with lower levels over time. Methods: We measured VEGF-A levels in 46 CHD death cases and a 14% random sample of 2321 community participants who were free of self-reported CHD at baseline. Traditional CHD risk factors such as age, gender, family history of CHD, cigarette smoking, hypertension, total cholesterol/HDL ratio, diabetes mellitus, were also evaluated at baseline. Mortality follow-up was determined through linkage of baseline data with the National Death Index. Results: During a median of 13 years of follow-up, 46 subjects died of coronary heart disease. Mean VEGF-A levels were significantly higher in the CHD death cases than among the random population sample (400 pg/ml vs. 303 pg/ml, p = 0.0004). In proportional hazards models adjusting for traditional risk factors, the hazard ratios (95%CI) for CHD death associated with increasing tertiles of VEGF-A were 1.0 (referent), 2.12 (0.74, 6.10), and 3.85 (1.37, 10.78), respectively (Ptest for trend = 0.008). Conclusion: In this population-based prospective, case-cohort study, baseline levels of VEGF-A showed a significant independent association with the risk of CHD death.

AB - Background: Autopsy data suggest that plaque neovascularization may be associated with coronary heart disease (CHD) death. Since vascular endothelial growth factor-A (VEGF-A) is upregulated in angiogenesis and therefore neovascularization, we hypothesized that individuals with elevated levels of VEGF-A at baseline would be a greater risk of dying of CHD compared to those with lower levels over time. Methods: We measured VEGF-A levels in 46 CHD death cases and a 14% random sample of 2321 community participants who were free of self-reported CHD at baseline. Traditional CHD risk factors such as age, gender, family history of CHD, cigarette smoking, hypertension, total cholesterol/HDL ratio, diabetes mellitus, were also evaluated at baseline. Mortality follow-up was determined through linkage of baseline data with the National Death Index. Results: During a median of 13 years of follow-up, 46 subjects died of coronary heart disease. Mean VEGF-A levels were significantly higher in the CHD death cases than among the random population sample (400 pg/ml vs. 303 pg/ml, p = 0.0004). In proportional hazards models adjusting for traditional risk factors, the hazard ratios (95%CI) for CHD death associated with increasing tertiles of VEGF-A were 1.0 (referent), 2.12 (0.74, 6.10), and 3.85 (1.37, 10.78), respectively (Ptest for trend = 0.008). Conclusion: In this population-based prospective, case-cohort study, baseline levels of VEGF-A showed a significant independent association with the risk of CHD death.

KW - Coronary heart disease

KW - hs-CRP

KW - VEGF-A

UR - http://www.scopus.com/inward/record.url?scp=49749132363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49749132363&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2007.12.027

DO - 10.1016/j.atherosclerosis.2007.12.027

M3 - Article

C2 - 18261732

AN - SCOPUS:49749132363

VL - 200

SP - 221

EP - 227

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 1

ER -